Infection with SARS-CoV-2 has a significant impact on cognitive function in patients with preexisting dementia, according to new research led by health experts from West Bengal.
Since the first wave of Covid-19, neurologists have noticed both acute and long-term neurological impact of this infectious disease. While insights Covid's effect on human cognition has remained unclear, neurologists have often referred to it as "brain fog" -- an ambiguous terminology.
To better describe the cognitive effects, the team proposed a new term: 'FADE-IN MEMORY' (that is, fatigue, decreased fluency, attention deficit, depression, executive dysfunction, slowed information processing speed, and subcortical memory impairment)."
They investigated the effects of Covid-19 on cognitive impairment in 14 patients with preexisting dementia (four with Alzheimer's, five with vascular dementia, three with Parkinson's, and two with the behavioural variant of frontotemporal dementia), who had suffered further cognitive deterioration following Covid-19.
The results, published in the Journal of Alzheimer's Disease Reports, showed that patients with all subtypes of dementia experienced rapidly progressive dementia following infection with SARS-CoV-2.
"As the ageing population and dementia are increasing globally, we believe pattern recognition of Covid-19-associated cognitive deficits is urgently needed to distinguish between Covid-19-associated cognitive impairments per se and other types of dementia," said Dr. Souvik Dubey, from the Department of Neuromedicine, at Bangur Institute of Neurosciences (BIN), Kolkata.
"This understanding will have a definitive impact on future dementia research," he added.
In addition, the team found that irrespective of patients' previous dementia types, the line of demarcation between different types of dementia became remarkably blurry post-Covid.
Researchers also found that the characteristics of a particular type of dementia changed following Covid-19, and both degenerative and vascular dementia started behaving like mixed dementia both clinically and radiologically.
A rapidly and aggressively deteriorating course was observed in patients having insidious onset, slowly progressive dementia, and who were previously cognitively stable.
The rapid progression of dementia, the addition of further impairments/deterioration of cognitive abilities, and the increase or new appearance of white matter lesions suggest that previously compromised brains have little defence to withstand a new onslaught (that is, a "second hit" like infection/dysregulated immune response and inflammation), they explained.
--IANS
rvt/svn/
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)